GlassScriptPhysician profile
Michele Bellamy
NPI 1134194863
$983.97
in general payments reported to CMS, 2019-2025
21 companies · $250 in 2025
The $250 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $361 · 2020: $174 · 2023: $62.88 · 2024: $136 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $448.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $146.68 | 2019-2020 | |
| Abbvie INC. | $142.56 | 2023-2025 | Ubrelvy, Vraylar |
| Pfizer INC. | $122.90 | 2019-2025 | |
| Amgen INC. | $89.03 | 2019-2020 | |
| Novo Nordisk INC | $84.14 | 2019-2025 | Rybelsus, Ozempic |
| Sumitomo Pharma America, INC. | $58.60 | 2024-2025 | Gemtesa |
| Lilly USA, LLC | $48.85 | 2019-2025 | Mounjaro, Zepbound |
| Supernus Pharmaceuticals, INC. | $40.15 | 2019 | |
| Glaxosmithkline, LLC. | $33.72 | 2024-2025 | Arexvy, Bexsero, Shingrix |
| Takeda Pharmaceuticals U.S.A., INC. | $32.10 | 2019-2020 | |
| Amarin Pharma, INC. | $31.24 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.78 | 2019 | |
| Phathom Pharmaceuticals, INC. | $17.73 | 2024 | Voquezna |
| Merck Sharp & Dohme LLC | $16.72 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.64 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $15.95 | 2024 | Veozah |
| Kowa Pharmaceuticals America, INC. | $15.84 | 2019 | |
| Ironshore Pharmaceuticals INC. | $14.69 | 2019 | |
| Exact Sciences Corporation | $14.22 | 2025 | Cologuard Collection Kit |
| Vertical Pharmaceuticals, LLC | $12.05 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michele Bellamy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.